DK104463C - Process for the preparation of 5-nitro-2-furyl-4H-1,2,4-triazoles. - Google Patents

Process for the preparation of 5-nitro-2-furyl-4H-1,2,4-triazoles.

Info

Publication number
DK104463C
DK104463C DK629964AA DK629964A DK104463C DK 104463 C DK104463 C DK 104463C DK 629964A A DK629964A A DK 629964AA DK 629964 A DK629964 A DK 629964A DK 104463 C DK104463 C DK 104463C
Authority
DK
Denmark
Prior art keywords
triazoles
furyl
nitro
preparation
Prior art date
Application number
DK629964AA
Other languages
Danish (da)
Original Assignee
Norwich Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharma Co filed Critical Norwich Pharma Co
Application granted granted Critical
Publication of DK104463C publication Critical patent/DK104463C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/74—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK629964AA 1964-01-09 1964-12-22 Process for the preparation of 5-nitro-2-furyl-4H-1,2,4-triazoles. DK104463C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33664364A 1964-01-09 1964-01-09

Publications (1)

Publication Number Publication Date
DK104463C true DK104463C (en) 1966-05-23

Family

ID=23317025

Family Applications (1)

Application Number Title Priority Date Filing Date
DK629964AA DK104463C (en) 1964-01-09 1964-12-22 Process for the preparation of 5-nitro-2-furyl-4H-1,2,4-triazoles.

Country Status (4)

Country Link
AT (1) AT246129B (en)
DK (1) DK104463C (en)
ES (1) ES306495A1 (en)
FR (2) FR1084E (en)

Also Published As

Publication number Publication date
FR1084E (en) 1903-05-25
ES306495A1 (en) 1965-03-01
AT246129B (en) 1966-04-12
FR3944M (en) 1966-02-21

Similar Documents

Publication Publication Date Title
DK125553B (en) Process for the preparation of substituted 2,4-diamino-5-benzylpyrimidines.
DK120546B (en) Process for the preparation of 2,4-diamino-5-benzylpyrimidines.
DK117957B (en) Process for the preparation of 13β-alkyl-3-oxogona-4,9,11-trienes.
DK116441B (en) Process for the preparation of 10,11-dihydro-dibenzo- (b, f) -thiepine derivatives.
DK129126B (en) Process for the preparation of 1,4-benzodiazepines.
DK112523B (en) Process for the preparation of 2,3-pyridinediol.
DK120752B (en) Process for the preparation of 5-aryl-3H-1,4-benzodiazepine-4-oxides.
DK108921C (en) Process for the preparation of tetrahydro-1,3,5-thiadiazin-2-thiones.
DK116219B (en) Process for the preparation of 1,2,4-triazoles.
DK112033B (en) Process for the preparation of 3-oxo-13β-alkyl-17β-hydroxy-17α-ethinylgona-5 (10), 9 (11) -diene.
DK114273B (en) Process for the preparation of α-methyl-α-amino-β- (3,4-disubstituted-phenyl) -propionitriles.
DK115184B (en) Process for the preparation of 6,7-benzomorphans.
DK131903B (en) Process for the preparation of L - (-) - beta- (3,4-dihydroxyphenyl) -alpha-methylalanine.
DK114556B (en) Process for the preparation of 1,4-benzodiazepin-2-one-4-oxides.
DK116357B (en) Process for the preparation of 1,1,1,2,2-pentafluoro-3-chloropropane.
DK112031B (en) Process for the preparation of 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-triene.
DK116594B (en) Process for the preparation of 4,1,5-benzoxadiazocines.
DK114962B (en) Process for the preparation of α, α, α ', α'-tetramethyl-xylylene dicarbinols.
DK120131B (en) Process for the preparation of 3-oxo-13β-alkylgona-4,9,11-trienes.
DK115622B (en) Process for the preparation of 3-oxogona-4,9,11-trienes.
DK106329C (en) Process for the preparation of 3,20-dioxo-19-nor-4,9,11-pregnatrien.
DK113917B (en) Process for the preparation of 2,2,6,6-tetrachlorocyclohexanone.
DK109895C (en) Process for the preparation of 1,3-dioxo-2-alkyl-cyclopentanes.
DK114904B (en) Process for the preparation of 3,5-diiodothyronines.
DK109639C (en) Process for the preparation of 3-oxo-17β-hydroxy-17α-methylestra-4,9,11-triene.